Orexin B, human is an endogenous agonist at Orexin receptor with Kis of 420 and 36 nM for OX1 and OX2, respectively.
CAT No: 10-101-319
CAS No:205640-91-1
Synonyms/Alias:Orexin B (human);205640-91-1;Orexin B, human TFA;Human orexin B TFA;(Met-28 = C-terminal amide);RSGPPGLQGRLQRLLQASGNHAAGILTM;C123H212N44O35S;HB5323;AKOS024456609;Orexin B (human) trifluoroacetate salt;FO109202;PD079176;H-Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala -Gly-Ile-Leu-Thr-Met-NH2; H-RSGPPGLQGR LQRLLQASGNHAAGILTM-NH2;
3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.